Valganciclovir Treatment Report

Category: Prescription Drugs

Most Popular Types: Valcyte

true

Generic Name: Valganciclovir

What is Valganciclovir?

An example of Valganciclovir

Valganciclovir is an antiviral agent used to treat cytomegalovirus (CMV) retinitis in patients with acquired immunodeficiency syndrome, and prevention of CMV disease in high-risk patients undergoing kidney, heart, or kidney/pancreas transplantation.

Reported Purpose & Perceived Effectiveness

Reasons and Perceived effectiveness
Perceived Effectiveness
Purpose # of patients # of patients with evaluations
Major
Moderate
Slight
None
Can’t tell
41 16 Efficacy_major Efficacy_moderate Efficacy_cant_tell
11 4 Efficacy_major Efficacy_cant_tell
6 3 Efficacy_major Efficacy_none Efficacy_cant_tell
5 2 Efficacy_major Efficacy_moderate
3 2 Efficacy_major Efficacy_moderate
3 0

See all 73 patients currently taking Valganciclovir

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
0
Moderate
0
Mild
7
None
21

Commonly reported side effects, conditions, and hospitalizations associated with Valganciclovir

1
1
1

Reported Dosages

  450mg as needed daily 450 mg every other week 450 mg m,w,f 450 mg daily 900 mg daily 1,800 mg daily
  1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 34 Number of Patients: 34 33 Number of Patients: 33 3 Number of Patients: 3  

Reported Stop Reasons

Why Patients Stopped Taking Valganciclovir (multiple reasons could be selected)
Reason # Patients Percentage of patients
Course of treatment ended 22   Course of treatment ended: 61%
Doctor's advice 15   Doctor's advice: 42%
Other 2   Other: 6%
Did not seem to work 1   Did not seem to work: 3%
Expense 1   Expense: 3%

See all 34 patients who’ve stopped taking Valganciclovir

Currently Taking Valganciclovir

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0

Stopped Taking Valganciclovir

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0

Reported Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Adherence of Valganciclovir

Always
26 93%
Usually
0 0%
Sometimes
0 0%
Never
2 7%

Burden

Difficulty being on treatment

Burden of Valganciclovir

Very
0 0%
Somewhat
1 4%
A little
2 7%
Not at all
25 89%

Cost

Paid out of pocket

Cost of Valganciclovir

$200+
0 0%
$100-199
0 0%
$50-99
3 20%
$25-49
2 13%
< $25
10 67%

Sort by: Helpfulness | Most Recent

7 patient evaluations for Valganciclovir

Purpose: Prevent infection (Started Oct 10, 2012)
Date Dosage Perceived effectiveness Side Effects Adherence Burden
Apr 13, 2013 900 mg Daily Led_efficacy_3Led_efficacy_3Led_efficacy_3Led_defaultModerate NoneNoneNoneNoneNone AlwaysAlwaysAlwaysAlwaysAlways A littleA littleA littleA littleA little
  • Icon_thumb_off 0 helpful marks
Purpose: Prevent infection (Started Nov 25, 2011)
Date Dosage Perceived effectiveness Side Effects Adherence Burden
May 25, 2012 450 mg Daily Led_efficacy_4Led_efficacy_4Led_efficacy_4Led_efficacy_4Major NoneNoneNoneNoneNone AlwaysAlwaysAlwaysAlwaysAlways Not at allNot at allNot at allNot at allNot at all
  • Icon_thumb_off 0 helpful marks
Purpose: Prevent infection (Started Sep 02, 2010)
Date Dosage Perceived effectiveness Side Effects Adherence Burden
Mar 15, 2011 900 mg Daily ?Can't tell MildMildMildMildMild AlwaysAlwaysAlwaysAlwaysAlways Not at allNot at allNot at allNot at allNot at all
  • Icon_thumb_off 0 helpful marks
1 2 3    You are at the first page First There is no previous page Prev | Next Go to the next page Last Go to the last page 

What is valganciclovir?

Valganciclovir is an antiviral drug. It works by preventing viral cells from multiplying in your body. Valganciclovir will not cure CMV but it can help control the infection.

Valganciclovir treats cytomegalovirus (CMV) infection of the eye in patients with acquired immunodeficiency syndrome (AIDS). Valganciclovir also prevents CMV infection in patients who have received an organ transplant (kidney, heart, or kidney-pancreas).

Valganciclovir may also be used for purposes other than those listed in this medication guide.

Your doctor may have switched you from ganciclovir (Cytovene) to valganciclovir (Valcyte). Be aware that the strength of these two medications is different. A valganciclovir tablet contains more medicine than a ganciclovir capsule. You may not need to use as many valganciclovir tablets as you did ganciclovir capsules. To avoid overdosage, take only as many valganciclovir tablets as your doctor has prescribed. An overdose of this medication can cause serious illness.


Precautions

Before taking this medication, tell your doctor if you have:

  • kidney disease,
  • liver disease, or
  • a blood cell disorder (such as anemia).

Tell your doctor if you are on hemodialysis or if you have recently had a radiation treatment.

Valganciclovir is in the FDA pregnancy category C. This means that it is not known if it will be harmful to an unborn baby. A similar drug called ganciclovir (Cytovene) did cause birth defects in animal studies. Using valganciclovir while you are pregnant could also cause harm to the unborn baby. Do not use this medication without telling your doctor if you are pregnant. Tell your doctor if you become pregnant during treatment.

If a man fathers a child while using valganciclovir, the baby may have birth defects. Use a condom to prevent pregnancy during your treatment. Continue using condoms for at least 90 days after you stop using valganciclovir.

This medication can affect fertility (your ability to have children), whether you are a man or a woman.

You should not breast-feed while you are using valganciclovir. It is not known if this medication passes into breast milk. If you have HIV or AIDS, you should not breast-feed at all. Even if your baby is born without HIV, you may still pass the virus to the baby in your breast milk.

Valganciclovir may cause cancer. Talk to your doctor about your individual risk.

If you have AIDS, follow your doctor’s instructions with respect to high-risk activities such as unprotected sex and the sharing of needles.

Use birth control to prevent pregnancy while you are using valganciclovir, whether you are a man or a woman. Valganciclovir use by either parent can cause birth defects. If you are a man, use a condom to keep from causing a pregnancy while you are taking valganciclovir. Continue using condoms for at least 90 days after you stop taking valganciclovir.

Valganciclovir can cause side effects that may impair your thinking or reactions. Be careful if you drive or do anything that requires you to be awake and alert.

Back to top

Instructions

Seek emergency medical attention if you think you have used too much of this medicine.

Symptoms of a valganciclovir overdose may include seizure (convulsions), kidney failure (urinating more or less than usual, blood in the urine, swelling or numbness in your hands or feet, pain in your lower back or sides), or signs of liver damage (yellowing of the skin or eyes, severe and sudden stomach pain, diarrhea, vomiting).

Take the missed dose as soon as you remember. If it is almost time for the next dose, skip the missed dose and take only the next regularly scheduled dose. Do not take extra medicine to make up the missed dose.

Back to top

Side Effects

Stop taking valganciclovir and seek emergency medical attention or contact your doctor immediately if you experience any of the following serious side effects:

  • an allergic reaction (difficulty breathing; closing of the throat; swelling of the lips, tongue, or face; or hives);
  • easy bruising, unusual bleeding;
  • numbness or tingling in a part of the body;
  • signs of infection (fever, chills, body aches, flu symptoms); or
  • seizure (convulsions).

Other, less serious side effects may be more likely to occur. Continue to take valganciclovir and talk to your doctor if you experience:

  • mild nausea, vomiting, diarrhea, stomach pain;
  • headache;
  • sleepiness or dizziness;
  • weakness, lack of coordination;
  • confusion;
  • tremor (uncontrolled shaking); or
  • sleep problems (insomnia).

Side effects other than those listed here may also occur. Talk to your doctor about any side effect that seems unusual or that is especially bothersome. You may report side effects to FDA at 1-800-FDA-1088.

Back to top

Interactions

Valganciclovir (Valcyte) and ganciclovir (Cytovene) must never be taken together.

Before taking valganciclovir, talk to your doctor if you are using any of the following drugs:

  • zidovudine (Retrovir, AZT);
  • didanosine (Videx, ddI);
  • mycophenolate (CellCept);
  • drugs that weaken your immune system (such as cancer medicine or steroids); or
  • probenecid (Benemid, Probalan).

If you are using any of these drugs, you may not be able to take valganciclovir, or you may require a dosage adjustment or special monitoring.

There may be other drugs not listed that can affect valganciclovir. Tell your doctor about all the prescription and over-the-counter medications you use. This includes vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start using a new medication without telling your doctor.

Other Names

Valcyte and valganciclovir

Back to top

Disclaimer

Every effort has been made to ensure that the information provided by Cerner Multum, Inc. ('Multum') is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Multum information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Multum does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Multum's drug information does not endorse drugs, diagnose patients or recommend therapy. Multum's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Multum does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 1996-2004 Cerner Multum, Inc. Version 2.05. Revision date 8/23/04

Last updated: